North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.495

-5.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: baggo who wrote (8)	10/1/1996 5:33:00 PM
From: andy harrison	of 82

I am a long time NVX bull and this is my rational for owning this stock: I believe that NVX is a change of Life Stock. You have to make sure that you are a buyer. You have to make sure that your buy enough You have to make sure that you hold it for the long term GOLDMAN SACH analyst earnings estimate as of 9.30.96 1997 $1.25/share 1998 $2.50/share up 100% 1999 $5.00/share up 100% PE OF 30/40 for a stock growing at 100% Gives us a price of $150/200 share. (No I am not smoking anything). These estimates only cover the following: DPaT DPaT + IPV (Polio) DPaT I IPV + HIB DPaT + HIB The following vaccines are further down the road: Adult Pertussis Menigitis A/B/C and Combo's of A/C; A/B; A/B/C Strep B (This has the potential of being the biggest blockbuster) Remember that Abbott Labs gives NVX a sales force of 500 people overnight. NVX would had serious trouble making a sales force so with Abbott as a partner they can concentrate on the vaccine and let the qualified Abbott salesforce book the sales. Lets keep the dialog going!!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next